{"transactions":[{"id":832687,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chairman"}}],"security":"common stock, par value $0.001","published_at":"2026-03-20T16:05:10.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":475424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 475,424 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on March 18, 2026."}],"balance_after":2276562,"source":{"system":"sec-edgar","filing":"0001038977-26-000002","document":"form4-03202026_040301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000103897726000002/form4-03202026_040301.xml","form_type":"4"}},{"id":942647,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-01-09T22:16:39.000Z","date":"2026-01-08","kind":"grant","planned":false,"acquired":true,"shares":622000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":9778086,"source":{"system":"sec-edgar","filing":"0001437749-26-001016","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774926001016/rdgdoc.xml","form_type":"4"}},{"id":1005221,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-11-07T22:01:49.000Z","date":"2025-11-05","kind":"gift","planned":false,"acquired":false,"shares":803717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the transfer of shares to The Weiss Family and Descendants Trust."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":9156086,"source":{"system":"sec-edgar","filing":"0001437749-25-033888","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925033888/rdgdoc.xml","form_type":"4"}},{"id":1005220,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-11-07T22:01:49.000Z","date":"2025-11-05","kind":"gift","planned":false,"acquired":false,"shares":3865126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents distribution of shares upon termination of the Michael Sean Weiss 2022 Grantor Retained Annuity Trust to irrevocable trusts for the benefit of Mr. Weiss' children."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":9959803,"source":{"system":"sec-edgar","filing":"0001437749-25-033888","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925033888/rdgdoc.xml","form_type":"4"}},{"id":1129621,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-05-30T11:21:17.000Z","date":"2025-05-30","kind":"other","planned":false,"acquired":false,"shares":187007,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of in connection with an offer made pursuant to the Agreement and Plan of Merger, dated as of March 9, 2025 and as amended on April 14, 2025 (the \"Merger Agreement\"), in exchange for $4.10 per share, net to the holder in cash, plus one contractual contingent value right (\"CVR\") per share. Each CVR represents the right to receive a payment ranging from $0.20 to $0.70 pursuant to certain milestone payments as defined in the Merger Agreement relating to the regulatory approval for cosibelimab in the European Union. The CVR milestone must be achieved within thirty-six (36) months after the date on which a marketing authorization application or equivalent application for cosibelimab receives a positive validation outcome by the European Medicines Agency."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares were held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-054698","document":"tm2516581-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465925054698/tm2516581-8_4seq1.xml","form_type":"4"}},{"id":1129620,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-05-30T11:21:17.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":1.29,"value":64500.0,"ownership":{"direct":true},"balance_after":187007,"source":{"system":"sec-edgar","filing":"0001104659-25-054698","document":"tm2516581-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465925054698/tm2516581-8_4seq1.xml","form_type":"4"}},{"id":1129619,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-05-30T11:21:17.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":12195,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares were held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member."}],"balance_after":137007,"source":{"system":"sec-edgar","filing":"0001104659-25-054698","document":"tm2516581-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465925054698/tm2516581-8_4seq1.xml","form_type":"4"}},{"id":1291148,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-01-30T22:17:24.000Z","date":"2025-01-29","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":13824929,"source":{"system":"sec-edgar","filing":"0001437749-25-002292","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774925002292/rdgdoc.xml","form_type":"4"}},{"id":1316026,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice Chairman"}}],"security":"common stock, par value $0.001","published_at":"2025-01-03T16:15:10.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":454153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 454,153 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2025."}],"balance_after":1801138,"source":{"system":"sec-edgar","filing":"0001415889-25-000402","document":"form4-01032025_040105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000141588925000402/form4-01032025_040105.xml","form_type":"4"}},{"id":1329459,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-12-17T21:33:54.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":12638,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on December 13, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member."}],"balance_after":124812,"source":{"system":"sec-edgar","filing":"0001104659-24-129528","document":"tm2431396-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465924129528/tm2431396-8_4seq1.xml","form_type":"4"}},{"id":1514699,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-05-16T19:35:27.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Weiss's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member."}],"balance_after":112174,"source":{"system":"sec-edgar","filing":"0001104659-24-062667","document":"tm2414703-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465924062667/tm2414703-6_4seq1.xml","form_type":"4"}},{"id":1514698,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-05-16T19:35:27.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":32051,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Weiss's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member."}],"balance_after":62174,"source":{"system":"sec-edgar","filing":"0001104659-24-062667","document":"tm2414703-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465924062667/tm2414703-6_4seq1.xml","form_type":"4"}},{"id":1684680,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2024-01-08T23:32:45.000Z","date":"2024-01-06","kind":"grant","planned":false,"acquired":true,"shares":1001908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":13074929,"source":{"system":"sec-edgar","filing":"0001437749-24-000899","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000143774924000899/rdgdoc.xml","form_type":"4"}},{"id":1693780,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2024-01-03T16:48:36.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":216465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 216,465 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2024."}],"balance_after":1346985,"source":{"system":"sec-edgar","filing":"0001104659-24-000900","document":"tm241755-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465924000900/tm241755-12_4seq1.xml","form_type":"4"}},{"id":1739520,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Warrants to purchase Common Stock","published_at":"2023-11-16T17:46:56.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":147058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70."}],"balance_after":147058,"derivative":{"exercise_price":1.7,"exercise_date":"2023-11-14","expiration_date":"2028-11-14","underlying":"Common Stock","underlying_shares":147058},"source":{"system":"sec-edgar","filing":"0001104659-23-119186","document":"tm2330934-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465923119186/tm2330934-1_4seq1.xml","form_type":"4"}},{"id":1739519,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-11-16T17:46:56.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":147058,"price":1.7,"value":249998.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split."}],"balance_after":1130520,"source":{"system":"sec-edgar","filing":"0001104659-23-119186","document":"tm2330934-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465923119186/tm2330934-1_4seq1.xml","form_type":"4"}},{"id":1809042,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2023-08-14T13:54:15.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":10.13,"value":1013000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price. The range of prices for the shares purchased was $10.11 to $10.17. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":12073021,"source":{"system":"sec-edgar","filing":"0001104659-23-091054","document":"tm2323684-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923091054/tm2323684-1_4seq1.xml","form_type":"4"}},{"id":1833130,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-07-07T16:06:36.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":7246,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted share units, which vest over various time periods."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":49637,"source":{"system":"sec-edgar","filing":"0001104659-23-079112","document":"tm2320790-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465923079112/tm2320790-3_4seq1.xml","form_type":"4"}},{"id":1854832,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-06-15T20:01:24.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":17483,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 17,483 shares of restricted Common Stock will vest on June 13, 2026, subject to Mr. Weiss's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Hawkins BioVentures, LLC, Mr. Weiss is the sole member."}],"balance_after":30123,"source":{"system":"sec-edgar","filing":"0001104659-23-071761","document":"tm2318836-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465923071761/tm2318836-6_4seq1.xml","form_type":"4"}},{"id":1932851,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-04-03T16:48:21.000Z","date":"2022-07-29","kind":"grant","planned":false,"acquired":true,"shares":71664,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 71,664 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 29, 2022. The shares will vest on June 17, 2025, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":135861,"source":{"system":"sec-edgar","filing":"0001104659-23-040923","document":"tm2311237d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465923040923/tm2311237d1_4seq1.xml","form_type":"4"}},{"id":1955172,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2023-03-14T21:00:32.000Z","date":"2023-03-12","kind":"grant","acquired":true,"shares":985000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted shares, which will vest and become non-forfeitable based on the Company's total shareholder return relative to the Nasdaq Biotechnology Index over a one-year to five-year period, provided that the Reporting Person remains an employee, director and/or consultant of the Company through each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted Common Stock, which vest over various time periods."}],"balance_after":11973021,"source":{"system":"sec-edgar","filing":"0001104659-23-032337","document":"tm239588-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465923032337/tm239588-1_4seq1.xml","form_type":"4"}},{"id":2017227,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-02-14T16:12:24.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":1197604,"price":0.835,"value":999999.34,"ownership":{"direct":true},"balance_after":14752034,"source":{"system":"sec-edgar","filing":"0001104659-23-021628","document":"tm236803-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465923021628/tm236803-6_4seq1.xml","form_type":"4"}},{"id":2069197,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-01-04T21:27:11.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":1219294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 1,219,294 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2023."}],"balance_after":13554430,"source":{"system":"sec-edgar","filing":"0001104659-23-001101","document":"tm231728-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465923001101/tm231728-7_4seq1.xml","form_type":"4"}},{"id":2203529,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (right to buy)","published_at":"2022-07-22T20:34:23.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":1900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects a grant of options relating to 2021 service and performance, of which 1/3 will vest on 7/20/2024, 1/3 will vest on 7/20/2025, and 1/3 will vest on 7/20/2026."}],"balance_after":1900000,"derivative":{"exercise_price":7,"expiration_date":"2027-07-20","underlying":"Common Stock, par value $0.001","underlying_shares":1900000},"source":{"system":"sec-edgar","filing":"0001104659-22-082027","document":"tm2221660-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922082027/tm2221660-7_4seq1.xml","form_type":"4"}},{"id":2222293,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-06-24T21:53:34.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":47619,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 47,619 shares of restricted Common Stock will vest on June 16, 2025, subject to Mr. Weiss's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":126401,"source":{"system":"sec-edgar","filing":"0001104659-22-074464","document":"tm2219319-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465922074464/tm2219319-1_4seq1.xml","form_type":"4"}},{"id":2288066,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2022-04-29T16:24:45.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":1102986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 1,102,986 restricted shares pursuant to the Issuer's Long Term Incentive Plan on January 1, 2022."}],"balance_after":12335136,"source":{"system":"sec-edgar","filing":"0001104659-22-053619","document":"tm2213913-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465922053619/tm2213913-8_4seq1.xml","form_type":"4"}},{"id":2440607,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2022-01-05","kind":"sale","acquired":false,"shares":30671,"price":18.31,"value":561586.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of 225,000 shares held by Mr. Weiss' dependents on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy tax withholding obligations. Mr. Weiss nor his dependents had any discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 2,437,005 shares received as a liquidating distribution from Opus Point Partners, LLC (\"Opus\"), of which Mr. Weiss was a principal. In prior reports, Mr, Weiss reported beneficial ownership of all 4,874,010 shares held by Opus, even though he only owned 50% of Opus. On December 29, 2021, as part of the dissolution of Opus the shares of TGTX held by Opus were distributed to the underlying Opus owners. As a result of such distribution, the 2,437,005 shares held indirectly by the reporting person are no longer held by the reporting person."}],"balance_after":10988021,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440606,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2022-01-04","kind":"sale","acquired":false,"shares":37549,"price":19.2,"value":720940.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the vesting of 225,000 shares held by Mr. Weiss' dependents on January 1, 2022, these shares were sold by the Company's restricted stock administrator in order to satisfy tax withholding obligations. Mr. Weiss nor his dependents had any discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock."}],"balance_after":13455697,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440605,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":56394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Reflects a grant of restricted shares of common stock of TG Therapeutics in lieu of cash compensation owed to Mr. Weiss for the 2021 fiscal year, which will fully vest on January 1, 2024."}],"balance_after":13493246,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440604,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2021-12-16","kind":"gift","acquired":false,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13436852,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440603,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2021-12-16","kind":"gift","acquired":false,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects the transfer of shares of TG Therapeutics stock to various trusts for the benefit of Mr. Weiss' dependents."}],"balance_after":13445852,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2440602,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2022-01-07T23:00:51.000Z","date":"2021-12-15","kind":"gift","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":14145852,"source":{"system":"sec-edgar","filing":"0001104659-22-002355","document":"tm222217d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465922002355/tm222217d2_4.xml","form_type":"4"}},{"id":2638607,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-07-08T16:32:56.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":13774,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"13,774 restricted shares were granted pursuant to the Issuer's 2016 Incentive Plan on June 28, 2021. The shares will vest on June 17, 2024, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":64197,"source":{"system":"sec-edgar","filing":"0001104659-21-090246","document":"tm2121675-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465921090246/tm2121675-5_4seq1.xml","form_type":"4"}},{"id":2659485,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2021-06-22T22:26:47.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":1080770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the final annual grant of restricted stock pursuant to the Strategic Advisory Agreement with Caribe BioAdvisors, LLC, pursuant to which Mr. Weiss provided the services of Chairman of the Board and Executive Chairman. The restricted shares will vest on the date that the Company's Market Capitalization is $500 million greater than the Market Capitalization on the date of grant as measured within a five-year timeframe, but in no event before December 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in Mr. Weiss' beneficial ownership are 4,909,355 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a principal and beneficially owns a 50% interest."}],"balance_after":14148852,"source":{"system":"sec-edgar","filing":"0001104659-21-084261","document":"tm2120405-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465921084261/tm2120405-6_4seq1.xml","form_type":"4"}},{"id":2672486,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-11T20:01:24.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":16502,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 16,502 shares of restricted Common Stock will vest on June 10, 2024, subject to Mr. Weiss's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":78782,"source":{"system":"sec-edgar","filing":"0001104659-21-080364","document":"tm2119513-5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465921080364/tm2119513-5_4.xml","form_type":"4"}},{"id":2752269,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-04-09T17:26:09.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":1030339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 1,030,339 restricted shares pursuant to the Issuer's Long Term Incentive Plan on January 1, 2021."}],"balance_after":11232150,"source":{"system":"sec-edgar","filing":"0001104659-21-048834","document":"tm219139d8_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465921048834/tm219139d8_4.xml","form_type":"4"}},{"id":2928026,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in Mr. Weiss' beneficial ownership are 4,909,355 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."}],"balance_after":13068082,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928025,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-28","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13068737,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928024,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-22","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13069737,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928023,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-15","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13069937,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928022,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-15","kind":"gift","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13070137,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928021,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-12-15","kind":"gift","acquired":false,"shares":834877,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to the Weiss Family and Descendants Trust."}],"balance_after":13071837,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928020,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-09-25","kind":"gift","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Reflect the transfer of shares as a bona fide gift to various 501(c)(3) charitable organizations."}],"balance_after":13906714,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":2928019,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-12-31T21:30:27.000Z","date":"2020-09-10","kind":"gift","acquired":false,"shares":525000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of shares of TG Therapeutics stock to the Weiss Family and Descendants Trust."}],"balance_after":13909214,"source":{"system":"sec-edgar","filing":"0001104659-20-140992","document":"tm2039708-1_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920140992/tm2039708-1_form5.xml","form_type":"5"}},{"id":3052701,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T16:33:15.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":16611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 50,423 restricted stock units which vest over time."}],"balance_after":50423,"source":{"system":"sec-edgar","filing":"0001104659-20-096926","document":"tm2028955d4_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465920096926/tm2028955d4_4.xml","form_type":"4"}},{"id":3101201,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2020-06-24T23:51:10.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":1556029,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual grant of restricted stock pursuant to the Strategic Advisory Agreement with Caribe BioAdvisors, LLC, pursuant to which Mr. Weiss provides the services of Chairman of the Board and Executive Chairman. The restricted shares will vest on the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on the date of grant, but in no event before December 31, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in Mr. Weiss' beneficial ownership are 4,910,010 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":14434214,"source":{"system":"sec-edgar","filing":"0001104659-20-076547","document":"tm2022959-7_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000110465920076547/tm2022959-7_4.xml","form_type":"4"}},{"id":3117143,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-09T16:33:21.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":24390,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 24,390 shares of restricted Common Stock will vest on June 5, 2023, subject to Mr. Weiss's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":62280,"source":{"system":"sec-edgar","filing":"0001104659-20-071414","document":"tm2022118d5_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465920071414/tm2022118d5_4.xml","form_type":"4"}},{"id":3211522,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE VICE CHAIRMAN"}}],"security":"Common Stock","published_at":"2020-03-13T16:08:47.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":801536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 801,536 restricted shares pursuant to the Issuer's Long Term Incentive Plan on January 1, 2020."}],"balance_after":10201811,"source":{"system":"sec-edgar","filing":"0001104659-20-033118","document":"tm2011481-8_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465920033118/tm2011481-8_form4.xml","form_type":"4"}},{"id":3308388,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-17T17:43:21.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":13812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,812 restricted stock units which vest over time."}],"balance_after":33812,"source":{"system":"sec-edgar","filing":"0001104659-20-005209","document":"tm203350d2_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465920005209/tm203350d2_form4.xml","form_type":"4"}},{"id":3308387,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-17T17:43:21.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 20,000 restricted stock units which vest over time."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-20-005209","document":"tm203350d2_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000110465920005209/tm203350d2_form4.xml","form_type":"4"}},{"id":3477449,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2019-06-27T11:33:16.000Z","date":"2019-06-26","kind":"purchase","acquired":true,"shares":50000,"price":7.035,"value":351750.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Weiss purchased 50,000 shares in the open market at a price of $7.035 per share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in Mr. Weiss' beneficial ownership are 4,910,010 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":12878185,"source":{"system":"sec-edgar","filing":"0001654954-19-007706","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495419007706/section16.xml","form_type":"4"}},{"id":3490408,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2019-06-14T20:43:22.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":1179380,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual grant of restricted stock pursuant to the Strategic Advisory Agreement with Caribe BioAdvisors, LLC, pursuant to which Mr. Weiss provides the services of Chairman of the Board and Executive Chairman. The restricted shares will vest on the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on the date of grant, but in no event before January 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in Mr. Weiss' beneficial ownership are 4,910,010 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":12828185,"source":{"system":"sec-edgar","filing":"0001654954-19-007359","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495419007359/section16.xml","form_type":"4"}},{"id":3490024,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-06-14T16:50:36.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":11442,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 11,442 shares of restricted Common Stock will vest on June 13, 2022, subject to Mr. Weiss's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":37890,"source":{"system":"sec-edgar","filing":"0001144204-19-031023","document":"tv523634_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000114420419031023/tv523634_4.xml","form_type":"4"}},{"id":3556836,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE VICE CHAIRMAN"}}],"security":"Common Stock","published_at":"2019-04-12T16:11:17.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":648204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 586,428, 164,473 and 648,204 restricted shares pursuant to the Company's Long Term Incentive Plan on January 1, 2018, July 3, 2018 and January 1, 2019, respectively."}],"balance_after":9400275,"source":{"system":"sec-edgar","filing":"0001144204-19-019502","document":"tv516222_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000114420419019502/tv516222_4.xml","form_type":"4"}},{"id":3556835,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE VICE CHAIRMAN"}}],"security":"Common Stock","published_at":"2019-04-12T16:11:17.000Z","date":"2018-07-03","kind":"grant","acquired":true,"shares":164473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 586,428, 164,473 and 648,204 restricted shares pursuant to the Company's Long Term Incentive Plan on January 1, 2018, July 3, 2018 and January 1, 2019, respectively."}],"balance_after":8752071,"source":{"system":"sec-edgar","filing":"0001144204-19-019502","document":"tv516222_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000114420419019502/tv516222_4.xml","form_type":"4"}},{"id":3556834,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"EXECUTIVE VICE CHAIRMAN"}}],"security":"Common Stock","published_at":"2019-04-12T16:11:17.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":586428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 586,428, 164,473 and 648,204 restricted shares pursuant to the Company's Long Term Incentive Plan on January 1, 2018, July 3, 2018 and January 1, 2019, respectively."}],"balance_after":8587598,"source":{"system":"sec-edgar","filing":"0001144204-19-019502","document":"tv516222_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000114420419019502/tv516222_4.xml","form_type":"4"}},{"id":3849885,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-08T21:40:33.000Z","date":"2018-08-07","kind":"gift","acquired":true,"shares":14663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 14,663 shares of restricted common stock will vest on August 7, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,663 shares of restricted stock."}],"balance_after":24663,"source":{"system":"sec-edgar","filing":"0001144204-18-042952","document":"tv500465_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000114420418042952/tv500465_form4.xml","form_type":"4"}},{"id":3881651,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2018-06-28T21:00:30.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":1018011,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an annual grant of restricted stock pursuant to the Strategic Advisory Agreement with Caribe BioAdvisors, LLC, pursuant to which Mr. Weiss provides the services of Chairman of the Board and Executive Chairman. The restricted shares will vest on the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in Mr. Weiss' beneficial ownership are 4,910,010 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":11648805,"source":{"system":"sec-edgar","filing":"0001654954-18-007119","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495418007119/section16.xml","form_type":"4"}},{"id":3892826,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-06-15T17:21:08.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":16448,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 3"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 16,448 shares of restricted Common Stock will vest on June 14, 2021, subject to Mr. Weiss's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares of restricted Common Stock which vest over various time periods."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":26448,"source":{"system":"sec-edgar","filing":"0001144204-18-034452","document":"tv496605_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000114420418034452/tv496605_form4.xml","form_type":"4"}},{"id":4278013,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK (RESTRICTED)","published_at":"2017-06-19T22:16:25.000Z","date":"2017-06-19","kind":"grant","acquired":true,"shares":834877,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Reflects an annual grant of restricted stock pursuant to the Strategic Advisory Agreement with Caribe BioAdvisors, LLC, pursuant to which Mr. Weiss provides the services of Chairman of the Board and Executive Chairman. The restricted shares will vest on the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on the date of grant; provided however, if the market capitalization threshold is met prior to June 30, 2018 then the shares shall vest on June 30, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Included in Mr. Weiss' beneficial ownership are 4,910,010 shares of Common Stock issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":10630794,"source":{"system":"sec-edgar","filing":"0001654954-17-005710","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495417005710/section16.xml","form_type":"4"}},{"id":4278012,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"COMMON STOCK","published_at":"2017-06-19T22:16:25.000Z","date":"2017-06-19","kind":"gift","acquired":false,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reflects the transfer of 350,000 shares of TG Therapeutics stock to the Weiss Family and Descendants Trust."}],"balance_after":9795917,"source":{"system":"sec-edgar","filing":"0001654954-17-005710","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000165495417005710/section16.xml","form_type":"4"}},{"id":4281136,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2017-06-15T17:16:31.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 2"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 10,000 shares of restricted Common Stock will vest on June 15, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The 10,000 shares of restricted Common Stock will vest on June 15, 2020."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares were issued to and are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001144204-17-032761","document":"v469071_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000114420417032761/v469071_form4.xml","form_type":"4"}},{"id":4479413,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Exec. VC - Strategic Dev."}}],"security":"Common Stock, par value $0.001","published_at":"2017-01-27T16:22:06.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":552698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan."}],"balance_after":8001170,"source":{"system":"sec-edgar","filing":"0001638599-17-000117","document":"doc4_4440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1038977/000163859917000117/doc4_4440.xml","form_type":"4"}},{"id":4504296,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO and President"}}],"security":"Common Stock (Restricted)","published_at":"2017-01-04T21:33:57.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":693750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Reflects an annual grant of restricted stock pursuant to Mr. Weiss? employment agreement to be held by Caribe BioAdvisors, LLC. The restricted shares will vest according to the following schedule: 25% on January 1, 2018; 25% on January 1, 2019; and 50% on the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on December 31, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":10145917,"source":{"system":"sec-edgar","filing":"0001354488-17-000033","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000135448817000033/issuerdirect_section16.xml","form_type":"4"}},{"id":4504295,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO and President"}}],"security":"Common Stock (Restricted)","published_at":"2017-01-04T21:33:57.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":418371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"375,000 shares vest on December 1, 2018 and 43,371 shares vest on December 1, 2019."}],"balance_after":9452167,"source":{"system":"sec-edgar","filing":"0001354488-17-000033","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000135448817000033/issuerdirect_section16.xml","form_type":"4"}},{"id":4504294,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO and President"}}],"security":"Common Stock (Restricted)","published_at":"2017-01-04T21:33:57.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":2960000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Note 4"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of restricted stock which vest based on certain market capitalization milestones."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The shares are held by Caribe BioAdvisors, LLC, of which Mr. Weiss is the sole member."}],"balance_after":9033796,"source":{"system":"sec-edgar","filing":"0001354488-17-000033","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000135448817000033/issuerdirect_section16.xml","form_type":"4"}},{"id":4504293,"issuer":{"id":3608,"kind":"organization","name":"TG THERAPEUTICS, INC.","symbol":"TGTX"},"owners":[{"id":56902,"kind":"person","name":"WEISS MICHAEL S","position":1,"cik":"0001038977","reported_name":"WEISS MICHAEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"CEO and President"}}],"security":"Common Stock (Restricted)","published_at":"2017-01-04T21:33:57.000Z","date":"2017-01-01","kind":"disposition_to_issuer","acquired":false,"shares":3381866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Weiss forfeited the shares pursuant to an amendment to his employment agreement effective as of January 1, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Included in Mr. Weiss' beneficial ownership are 4,499,560 shares of Common Stock and 410,450 warrants to purchase Common Stock at $2.48, exercisable through February 24, 2017 issued to Opus Point Partners, LLC, of which Mr. Weiss is a co-founder, managing partner, and principal and beneficially owns a 50% interest."}],"balance_after":6073796,"source":{"system":"sec-edgar","filing":"0001354488-17-000033","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1001316/000135448817000033/issuerdirect_section16.xml","form_type":"4"}}]}